Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
1.190
+0.110 (10.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
Generation Bio Co. Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 18.58 | 5.9 | - | - | - | - | |
| Cost of Revenue | 60.02 | 79.82 | 74.2 | 74.72 | 49.14 | - | |
| Gross Profit | -41.44 | -73.91 | -74.2 | -74.72 | -49.14 | - | |
| Selling, General & Admin | 55.84 | 64.65 | 66.98 | 44.38 | 31.98 | 21.72 | |
| Research & Development | - | - | - | - | - | 40.58 | |
| Operating Expenses | 55.84 | 64.65 | 66.98 | 44.38 | 31.98 | 62.3 | |
| Operating Income | -97.27 | -138.56 | -141.18 | -119.1 | -81.11 | -62.3 | |
| Interest & Investment Income | 8.5 | - | - | - | - | 0.98 | |
| Other Non Operating Income (Expenses) | 3.28 | 11.95 | 4.54 | -0.05 | 0.59 | - | |
| EBT Excluding Unusual Items | -85.5 | -126.61 | -136.64 | -119.15 | -80.52 | -61.33 | |
| Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.01 | |
| Pretax Income | -145.47 | -126.61 | -136.64 | -119.15 | -80.52 | -61.32 | |
| Net Income | -145.47 | -126.61 | -136.64 | -119.15 | -80.52 | -61.32 | |
| Net Income to Common | -145.47 | -126.61 | -136.64 | -119.15 | -80.52 | -61.32 | |
| Shares Outstanding (Basic) | 66 | 64 | 58 | 56 | 27 | 5 | |
| Shares Outstanding (Diluted) | 66 | 64 | 58 | 56 | 27 | 5 | |
| Shares Change (YoY) | 5.77% | 10.96% | 3.23% | 106.54% | 476.06% | 41.22% | |
| EPS (Basic) | -2.19 | -1.96 | -2.35 | -2.12 | -2.95 | -12.96 | |
| EPS (Diluted) | -2.19 | -1.96 | -2.35 | -2.12 | -2.95 | -12.96 | |
| Free Cash Flow | -104.36 | -60.14 | -111.25 | -97.78 | -75.66 | -60.33 | |
| Free Cash Flow Per Share | -1.57 | -0.93 | -1.91 | -1.74 | -2.78 | -12.75 | |
| Gross Margin | -222.99% | - | - | - | - | - | |
| Operating Margin | -523.47% | -2346.93% | - | - | - | - | |
| Profit Margin | -782.87% | -2144.51% | - | - | - | - | |
| Free Cash Flow Margin | -561.62% | -1018.67% | - | - | - | - | |
| EBITDA | -92.19 | -133.3 | -136.05 | -114.57 | -77.68 | -60.44 | |
| D&A For EBITDA | 5.08 | 5.26 | 5.13 | 4.53 | 3.43 | 1.86 | |
| EBIT | -97.27 | -138.56 | -141.18 | -119.1 | -81.11 | -62.3 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.